 |
|
| Keynote Speaker biographies |
|
 |
|
 |
Nick Lynch
Chemistry Domain Architect at AstraZeneca and Chairman of PISTOIA Alliance
The primary purpose of the Pistoia Alliance is to streamline non-competitive elements of the pharmaceutical drug discovery workflow by the specification of common business terms, relationships and processes.
Every pharma company & software vendor is challenged by the technical interconversion, collation and interpretation of drug/agrochemical discovery data and as such, there is a vast amount of duplication, conversion and testing that could be reduced if a common foundation of data standards, ontologies and web-services could be promoted and ideally agreed within a nonproprietary and non-competitive framework. This would allow interoperability between a traditionally diverse set of technologies to benefit the healthcare sector. Through global collaboration, this pragmatic community will derive and instantiate and make available web-services for consumption by Academic institutions, Vendors and Companies under an Open Source framework.
We will describe current progress, learnings and how companies, academics and others can participate in this approach.
http://www.pistoiaalliance.org |
|
John Aisien
VP Product Management, Oracle Fusion Middleware, EMEA
John represents the Fusion Middleware development organization in EMEA and leads a team of product managers that deliver field support to a virtual go to market team across the EMEA region. His responsibilities include development of sales and product adoption programs for the region, implementation of region-specific product & market positioning, regional competitive analysis, sales enablement and customer lifecycle management.
John joined Oracle as vice president of product management, identity management, where he led global business enablement and helped establish Oracle as a significant identity management anchor brand.
Before joining Oracle, he drove Thor Technologies' marketing and business development strategies, which culminated in Thor’s acquisition by Oracle in November 2005.
|
|
Gill Devine
Senior Director, Life Sciences EMEA
In a recent IDC report Oracle were Named as the Number 1 software vendor to the Life Sciences industry.
Gill is the Life Science lead in the Healthcare and Life Sciences Industry Business Unit in EMEA and leads a team of Business Development Directors and Technical Directors that deliver field support to all Life Science accounts. Her responsibilities include development of sales campaigns for the region, implementation of region and industry specific product & market positioning, competitive analysis, business development and thought leadership. Her team also serve as key ambassadors at Life Science events, conferences, with regulatory and government bodies and other relevant forums.
Gill joined Oracle as director for Life Sciences in the International Account Sales Team and has since been promoted to Senior Director in the HC & LS IBU.
Before joining Oracle, Gill was Senior Director for Life Sciences at BEA where she lead Business Development activities Globally into BEA’s large pharmaceutical accounts. |
|
 |
|
